aTyr Pharma Inc. | Income Statement
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Cost of Goods Sold (COGS) incl. D&A
714.00
829.00
869.00
900.00
713.00
746
Gross Income
714.00
829.00
869.00
900.00
713.00
746
SG&A Expense
18,828.00
22,725.00
46,747.00
58,440.00
46,432.00
32,074
EBIT
19,542.00
23,554.00
47,616.00
59,340.00
47,145.00
32,820
Unusual Expense
28.00
36.00
29.00
1,371.00
-
-
Non Operating Income/Expense
-
-
-
-
1,062.00
1,695
Interest Expense
444.00
832.00
386.00
-
-
-
Pretax Income
20,014.00
24,350.00
47,973.00
57,904.00
48,207.00
34,515
Income Tax
-
-
-
49.00
-
-
Consolidated Net Income
21,651.00
24,350.00
47,973.00
57,855.00
48,207.00
34,515
Net Income
21,651.00
24,350.00
47,973.00
57,855.00
48,207.00
34,515
Net Income After Extraordinaries
21,651.00
24,350.00
47,973.00
57,855.00
48,207.00
34,515
Net Income Available to Common
21,651.00
24,766.00
47,988.00
57,855.00
48,207.00
34,515
EPS (Basic)
0.93
1.06
3.03
2.44
1.87
16.13
Basic Shares Outstanding
23,353.70
23,353.70
15,838.40
23,681.00
25,799.90
2,139.80
EPS (Diluted)
0.93
1.06
3.03
2.44
1.87
16.13
Diluted Shares Outstanding
23,353.70
23,353.70
15,838.40
23,681.00
25,799.90
2,139.80
EBITDA
18,828.00
22,725.00
46,747.00
58,440.00
46,432.00
32,074
Non-Operating Interest Income
-
-
-
65.00
-
-
Other After Tax Income (Expense)
1,637.00
-
-
-
-
-
Preferred Dividends
-
416.00
15.00
-
-
-
About aTyr Pharma
View Profile
